Daniel Zollinger
Daniel is the co-founder of okklo life sciences. He is a life sciences R&D expert with more than 20 years of international experience in the pharmaceutical industry.
Daniel is the co-founder of okklo life sciences. He is a life sciences R&D expert with more than 20 years of international experience in the pharmaceutical industry.
okklo life sciences will be participating in the upcoming 12th International Symposium on MPS and related diseases. This meeting will bring together some patients, their parents and families and professionals, providing a platform for sharing of information on all aspects of MPS and related disorders, in order to advance quality of care and treatment. The meeting will be held in …
As of early 2012, okklo life sciences has been located at the newly established Life Sciences Park in Oss, The Netherlands. In June, the address was also registered with the Chamber of Commerce , so that okklo now is an integral part of the rapidly growing community of companies that have been joining the Life …
June 2012 Alex Zwiers participated in CRS Nordic Chapter meeting on Drug Delivery and Targeting in Reykjavik, Iceland, June 3-5, 2012. The meeting was well attended and with a dedicated audience with a keen interest in novel (bio-medical) applications for cyclodextrins, this proved to be an excellent opportunity for okklo life sciences to strengthen relationships …
April 2012 Okklo life sciences was successful in obtaining a grant from Agentschap NL as a member of the IPC funding scheme. In this program, SMEs are required to enter into collaborative projects around selected themes leading to innovations. Okklo was the coordinating member for a group of five SMEs working in/around infectious diseases …
March 2012 Okklo life sciences was invited to attend to 6th B4B meeting organized in Frankfurt from March 9-11, 2012. Brains for Brain (B4B ) is an internationalTask Force on rare genetic diseases involving the brain. The task force is formed by outstanding scientists, clinicians and leaders in the neurological field, working together with biotech …
2 Feb 2012 okklo life sciences is entering a collaboration with UMC Radboud (Nijmegen, The Netherlands) for the development of novel therapeutic approaches against multi-drug resistant tuberculosis (MRD-TB). Resistance against treatment with antibiotics is increasingly common in many infectious diseases, and this also is a serious health issue concern …